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http://dx.doi.org/10.1016/j.stemcr.2016.07.009SUMMARYEmbryonic stem cells (ESCs) are cell lines derived from themammalian pre-implantation embryo. Herewe assess the impact of derivation
and culture conditions on both functional potency and ESC transcriptional identity. Individual ESCs cultured in either two small-mole-
cule inhibitors (2i) or with knockout serum replacement (KOSR), but not serum, can generate high-level chimeras regardless of how these
cells were derived. ESCs cultured in these conditions showed a transcriptional correlation with early pre-implantation embryos
(E1.5–E3.5) and contributed to development from the 2-cell stage. Conversely, the transcriptome of serum-cultured ESCs correlated
with later stages of development (E4.5), at which point embryonic cells are more restricted in their developmental potential. Thus,
ESC culture systems are not equivalent, but support cell types that resemble distinct developmental stages. Cells derived in one condition
can be reprogrammed to another developmental state merely by adaptation to another culture condition.INTRODUCTION
Embryonic stem cells (ESCs) are karyotypically normal,
self-renewing cell lines, derived from the inner cell mass
(ICM) of the pre-implantation embryo (Evans and Kauf-
man, 1981; Martin, 1981). ESCs can be derived and
expanded using a variety of conditions, including culture
with the cytokine leukemia inhibitory factor (LIF) in the
presence of serum (Smith et al., 1988; Williams et al.,
1988), in serum-free medium with two small-molecule in-
hibitors (2i) (Ying et al., 2008), or with knockout serum
replacement (KOSR) (Ward et al., 2002). ESCs can be main-
tained indefinitely in vitro, while retaining the capacity to
participate in development and generate all cell types of
the embryo including the germ cells (Beddington and
Robertson, 1989; Gossler et al., 1986; Lallemand and Bru-
let, 1990; Robertson et al., 1986; Suemori et al., 1990).
They are therefore said to be pluripotent.
Although the first ESCs were derived more than 30 years
ago, a number of fundamental questions remain un-
answered. At the embryonic stages from which ESCs are
derived, the blastocyst is composed of several cell types,
the epiblast (Epi), primitive endoderm (PrE), and tro-
phoblast, and, during ESC derivation, subpopulations of
embryo-derived cells are selected to expand. While these
populations are not the same as the parental embryonic
cells from which they are derived (Tang et al., 2010), to
what degree do they represent embryonic development?
ESC cultures are also heterogeneous (Canham et al.,
2010; Chambers et al., 2007; Hayashi et al., 2008; Kobaya-Stem C
This is an open access article under the Cshi et al., 2009; Singh et al., 2007; Toyooka et al., 2008) and
this heterogeneity is dynamic, perhapsmore dynamic than
the blastocyst from which they are derived. However, does
this heterogeneity reflect the endogenous cell populations
that arise in normal blastocyst development?
The functional potential of ESCs can be assessed using a
number of different approaches including in vitro differen-
tiation, teratoma formation, and chimera generation (Bed-
dington and Robertson, 1989; Poueymirou et al., 2007;
Robertson et al., 1986; Saburi et al., 1997). Nevertheless,
as ESCs are heterogeneous and chimeras are routinely
generated by injecting 10–15 ESCs into morula or blasto-
cyst-stage embryos (Bradley et al., 1984; Lallemand and
Brulet, 1990) it is difficult to discern the functional proper-
ties of individual ESCs or specific ESC subpopulations.
Based on the prospective isolation of ESC subpopulations,
it has been shown that ESCs cultured in serum and LIF
contain dynamic populations of PrE- and Epi-biased cells
(Canham et al., 2010). However, these cells are clearly
different from the blastocyst from which they are derived,
as the PrE-primed cells express elevated levels of PrE RNA,
but not protein. ESCs cultured under these conditions
also contain a subpopulation that expresses 2-cell embryo
(2C)-specific genes (Falco et al., 2007; Macfarlan et al.,
2012). Similarly, culture of ESCs in 2i supports a totipotent
population of cells that coexpress Epi determinants such as
Nanog and the RNA for extraembryonic genes such as
Gata6 or Hhex (Morgani et al., 2013).
So, how do the conditions used to maintain ESCs influ-
ence the gene-expression state and populations containedell Reports j Vol. 7 j 177–191 j August 9, 2016 j ª 2016 The Authors. 177
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. KOSR and 2i Culture Enhances ESC Single-Cell Potency
ESCs were derived (D) in and cultured (C) under various conditions; D in serum and C in serum, D in serum and C in 2i, D in 2i and C in 2i,
and D in KOSR and C in KOSR.
(A and B) Multiple (5) ESCs were injected into morulae and their contribution to full-term chimeras assessed according to coat color.
(A) Graph showing the percentage of chimeras born out of the total number of pups and quantification of coat color chimerism. n Values are
(legend continued on next page)
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within the culture? In this paper we explore this question
by testing the impact of culture and derivation conditions
on ESC populations, comparing ESC gene expression and
heterogeneity, and the capacity of individual ESCs to
contribute to full-term embryonic development. We found
that ESCsmaintained in standard serum culture conditions
were comparable to populations of the late blastocyst
(embryonic day 4.5 [E4.5]) ICM, at which point cells are
specified and restricted in their functional potential.
Conversely, ESCs cultured in 2i or KOSR showed a correla-
tion with embryos from as early as the 2C stage, when cells
are unrestricted and highly plastic. Consistent with expres-
sion data, we observed that single 2i and KOSR, but not
serum, cultured ESCs could generate high-level chimeras
when injected into either morulae or 2C embryos. This
suggests that different ESC culture conditions support the
expansion of populations reminiscent of different embry-
onic stages with distinct functional potentials. We found
that populations induced during derivation could be ‘‘re-
programmed’’ by transferring ESCs to a different culture
condition.RESULTS
KOSR and 2i Culture Enhances ESC Single-Cell
Potency
ESC lines have been derived andmaintained in a number of
different medium compositions (Smith et al., 1988; Ward
et al., 2002; Williams et al., 1988; Ying et al., 2008). We
sought to compare the functional potential of individual
ESCs derived and/or maintained by different protocols.
As ESCs of different genetic backgrounds generate chimeras
with variable efficiencies (Auerbach et al., 2000; Brook and
Gardner, 1997), we wished to start with high-quality ESC
lines capable of generating chimeras from single cells. Weprovided above bars and refer to the number of independent ESC clon
conditions are a combination of ESCs cultured with and without mouse
have in serum and KOSR cultures. No difference was observed with
Student’s unpaired t test. (B) Representative images of litters of mic
(C and D) ESCs were cultured in serum, 2i, or KOSR and stained for alkal
(D) Quantification of ESC colony categories as defined in Figure S1C.
pendent ESC lines. ****p% 0.0001, two-tailed chi-square test.
(E and F) ESCs were cultured in serum, 2i, or KOSR and then differen
phosphatase activity. (E) Representative images of differentiated c
Figure S1C. Error bars represent SEM of three biological replicates of in
(G–I) Single ESCs were injected into morulae and their contribution
showing the percentage of chimeras born out of the total number of pu
above bars and refer to the number of independent ESC clones tested f
are a combination of ESCs cultured with and without MEFs to control
difference was observed with or without MEFs. (H and I) Represent
contribution.
See also Figure S1.therefore utilized mice from an F1 hybrid genetic back-
ground, reported to generate chimeras with high efficiency
based on hybrid vigor (Eggan et al., 2001). We derived
F1 129S2;C57BL/6N hybrid ESC lines in conventional
serum/LIF (serum) culture conditions, as well as 2i/LIF
(2i) and KOSR/LIF (KOSR). We confirmed that resulting
ESC lines were of high quality by standard injection of
multiple ESCs into morulae. ESC lines generated 100%
ESC-derived mice as judged by coat color and internal or-
gans (Figures 1A, 1B, S1A, and S1B; Table 1) and contrib-
uted to the germline (n = 15/15, Table 2). However, ESCs
derived in 2i, but switched to serum medium, showed a
significant reduction in their capacity to generate chimeras
in this assay (Figure 1A).
We also assessed the capacity of these ESC lines for clonal
self-renewal in vitro. Single ESCs were expanded and
stained for alkaline phosphatase activity, amarker of undif-
ferentiated cell types (Figures 1C–1F and S1C). While the
majority of 2i- and KOSR-cultured ESC colonies were
entirely undifferentiated, a significant fraction of serum-
cultured colonies exhibited some degree of differentiation
(Figures 1C and 1D). When challenged to differentiate in
the absence of the cytokine LIF, all ESCs efficiently differen-
tiated, although fewer colonies were entirely differentiated
when ESCs were previously cultured in 2i or KOSR (Figures
1E and 1F). This suggested that individual cells in these
conditions retain some intrinsic capacity to self-renew
despite exposure to differentiation-promoting signals.
There was no difference in the proliferation rate of ESCs
in each condition (Figure S1D).
After this initial validation of ESC lines, we wished char-
acterize the impact of serum, 2i, and KOSR culture on the
potency of individual ESCs. To this end we injected single
ESCs into morulae. Single ESCs, derived and cultured in
2i, generated 100% ESC-derived mice, as judged by coat
color (Figures 1G and 1H; Table 1). ESCs cultured in KOSRes tested for each condition. Error bars indicate SEM. Results for 2i
embryonic fibroblasts (MEFs) to control for the effect that MEFs may
or without MEFs. **p % 0.01, ***p % 0.001, ****p % 0.0001,
e. Asterisks indicate mice with ESC contribution.
ine phosphatase activity. (C) Representative images of ESC colonies.
Error bars represent SEM of three biological replicates using inde-
tiated by removal of LIF for 5 days. Cells were stained for alkaline
olonies. (F) Quantification of ESC colony categories as defined in
dependent ESC lines. ****p% 0.0001, two-tailed chi-square test.
to full-term chimeras assessed according to coat color. (G) Graph
ps and quantification of coat color chimerism. n Values are provided
or each condition. Error bars indicate SEM. Results for 2i conditions
for the effect that MEFs may have in serum and KOSR cultures. No
ative images of litters of mice. Asterisks indicate mice with ESC
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Table 1. Chimera Frequencies, Related to Figures 1 and 3
Condition Line
Injected/
Transferred
Chimeras/
Pups
1 ESC into Morula
D serum, C serum 3.4 + MEFS 25 0/11
3.2 + MEFs 25 0/2
D serum, C 2i 3.4 + MEFs 31 6/9
3.2 + MEFs 19 1/6
D 2i, C 2i 2.2H + MEFs 38 4/9
D KOSR, C KOSR 5.3 + MEFs 30 0/2
5.45 + MEFs i. 30
ii. 45
i. 0/5
ii. 2/8
5 ESCs into Morula
D serum, C serum 3.4 + MEFs i. 17
ii. 40
i. 3/5
ii. 1/2
3.2 + MEFs i. 24
ii. 30
i. 3/4
ii. 2/3
D serum, C 2i 3.4 + MEFs 12 4/4
3.2 + MEFs 20 2/6
D 2i, C 2i 2.2H + MEFs i. 25
ii. 56
i. 4/5
ii. 21/21
2.2Ack1#5 + MEFs 13 1/1
2.2Ack1#11 + MEFs 15 6/6
2.2Ack1#28 + MEFs 15 6/6
2.2Ack1#14 + MEFs 15 4/4
2.2PTIP#8 + MEFs 42 4/5
(1 < 100%)
2.2PTIP#9 + MEFs 30 4/4
D 2i, C serum 2.5 30 0/1
2.2 30 1/7
D KOSR, C KOSR 5.3 + MEFs 30 14/14
5.45 + MEFs 25 3/3
D KOSR, C serum 5.3 + MEFs 28 4/6
5.45 + MEFs 25 5/6
(5 < 100%)
1 ESC into 2C Embryo
D serum, C serum 3.4 + MEFs 24 0/6
3.2 + MEFs 13 0/8
D serum, C 2i 3.4 + MEFs 24 5/6
3.2 + MEFs 14 2/6
Table 1. Continued
Condition Line
Injected/
Transferred
Chimeras/
Pups
D 2i, C 2i 2.5 30 2/18
2.5 + MEFs 30 0/7
2.2 59 6/11
2.2 + MEFs 30 3/8
2.6 26 3/18
(1 < 100%)
2.2H + MEFs 24 7/14
(2 < 100%)
2.2V + MEFs 58 5/11
(1 < 100%)
D 2i, C serum 2.2 28 0/6
2.5 17 0/5
D KOSR, C KOSR 5.3 + MEFs 13 2/5
5.45 + MEFs 13 1/3
5 ESCs into 2C Embryo
D serum, C serum +
MEFs
3.4 48 0/3
D serum, C 2i + MEFs 3.4 40 6/7
ESCs were derived (D) in and cultured (C) under various conditions. Table
shows the number of embryos injected and transferred and the resulting
number of chimeras out of total pups born from each cell line under each
derivation and culture condition. Individual injection experiments of the
same clone are marked as (i) and (ii). Results are shown for single- and mul-
tiple-cell injection into morulae and single- and multiple-cell injection into
2-cell (2C) embryos.
180 Stem Cell Reports j Vol. 7 j 177–191 j August 9, 2016also demonstrated this capacity, albeit to a lower extent
(Figure 1G and Table 1). Conversely, ESCs derived and
cultured in serum did not generate full-term chimeras
when injected as single cells into morulae (Figures 1G
and 1H; Table 1).We also found that ESCs derived in serum
conditions were not inherently limited in their capacity to
generate chimeras as, after transient transfer of these cells
to 2i (three passages), single cells now contributed to em-
bryos (Figures 1G and 1I; Table 1). This suggests that in
chimera assays, as in vitro (Figures 1C and 1D), culture in
2i or KOSR increases the clonogenicity of ESCs compared
with standard serum culture.
2i- and KOSR-Cultured ESCs Represent Early Stages of
Embryonic Development
To determine the transcriptional landscape related to these
functional differences, we performed microarray expres-
sion analysis on ESCs cultured in these conditions (GEO:
GSE72445). When compared with serum cultures, 1,473
Table 2. Germline Contribution, Related to Figures 1 and 3
Condition Line
Experimental Setup Mice Were
Generated from:
1 ESC into
2C Embryo
5 ESCs into
Morula
D serum, C serum 3.2 – 1/1
3.4 – 1/1
D 2i, C 2i 2.2 3/3 3/3
2.5 1/1 2/2
2.6 1/1 1/1
D KOSR, C KOSR 5.3 – 2/2
5.45 – 2/2
F1 129S6;C57BL/6N ESCs were derived (D) in and cultured (C) under various
conditions. Chimeric mice were generated by different means (described in
table headings) and then tested for ESC germline contribution. Results show
the number of mice demonstrating germline transmission out of the number
of mice tested per condition.genes were upregulated and 2,249 genes were downregu-
lated in 2i, and 546 genes were upregulated and 493 genes
were downregulated in KOSR (Figure 2A, Tables S1–S4, FDR
%0.05, fold change R2). Genes upregulated in 2i and
KOSR showed a strong signature for lipid and glutathione
metabolism (Tables S5 and S6), while genes upregulated
in KOSR were also associated with meiosis and anterior-
posterior patterning (Table S6). Downregulated genes in
2i were associated with extracellular matrix, differentia-
tion, and the mitogen-activated protein kinase pathway
(Table S7). Similarly, genes downregulated in KOSR were
related to cell junctions, matrix adhesion, and fibroblast
growth factor (FGF) signaling (Table S8). Consistent with
previous reports (Marks et al., 2012; Morgani et al., 2013),
we also observed that 2i cultures downregulatedmesoderm
and ectoderm markers while having little effect on endo-
dermal gene expression (Figure 2B). However, KOSR culture
increased the expression of endoderm markers but had
little effect on pluripotent gene expression (Figure 2B).
The coexpression of pluripotency and extraembryonic
genes is an expression state previously associated with toti-
potency (Morgani et al., 2013).
As 2i- and KOSR-cultured ESCs both generated high-level
chimeras from single cells, we asked whether they shared a
common gene-expression signature. As serum-cultured
ESCs did not demonstrate this property, we overlapped
genes that were differentially expressed in 2i or KOSR
compared with standard serum cultures (Tables S1–S4)
and found a highly significant, non-random overlap (Fig-
ure 2C). In KOSR-cultured ESCs of annotated genes that
were significantly changing in expression, 46% of upregu-lated (representation factor 5.5, p < 8.1 3 1084) and 62%
of downregulated genes (representation factor 5.0, p <
6.7 3 10101) overlapped with those up- or downregulated
in 2i (Figure 2C and Table S9). Common upregulated genes
were associated with germ cell development, e.g., Dazl,
Hormad1, and Sohlh2, while downregulated genes were
enriched for adhesion, migration, and differentiation
markers, e.g., Lamb3, Egfr, and Neurod1 (Table S10).
As the correlation between KOSR-cultured ESCs and PrE
had not previously been reported, we investigated this in
more detail. We confirmed by qPCR that the PrE markers
Gata4, Gata6, Dab2, and FoxA2 were upregulated in KOSR
compared with either serum or 2i conditions (Figure S2A).
KOSR culture also resulted in elevated expression of aHhex-
Venus (HV) transgene, which marks a PrE-primed ESC
population (Canham et al., 2010) (Figure 2D).We observed
that expression of theNanog-GFP reporter (Chambers et al.,
2007) was increased in KOSR cultures compared with
serum cultures, although not to levels as high as in 2i (Fig-
ure 2E). In serum cultures, the PrE marker Hhex and the Epi
marker Nanog are expressed mutually exclusively, whereas
in 2i they are coexpressed (Canham et al., 2010; Morgani
et al., 2013). Similar observations were made in KOSR,
where the Hhex-expressing subpopulation contained a
high number of Nanog-positive cells (Figure S2B). We also
observed that KOSR cultures contained cells that coex-
pressed OCT4, SOX2, and GATA6 protein not observed in
either serum or 2i cultures (Figures 2F and S2C). Similar
observations were made by flow cytometry, as we observed
a fraction of ESCs expressing the PrE marker platelet-
derived growth factor receptor a (PDGFRa) in KOSR, but
not serum or 2i (Figures S2D and S2E).
As there were marked transcriptional and functional dif-
ferences between ESCs maintained in serum, 2i, or KOSR,
we asked how these expression states compared with
gene expression during embryonic development. We
compared our microarray data with expression data from
pre-implantation embryo populations (Ohnishi et al.,
2014) using ExAtlas (FDR%0.05, fold changeR2) (Sharov
et al., 2015). We observed a correlation between ESCs
cultured in 2i and KOSR and early embryos (E3.25) (Fig-
ure 2G and Table 3, z = 3.5 and 3.6, respectively), when
ICM cells are unspecified and have a wide functional po-
tency (Grabarek et al., 2012; Rossant and Lis, 1979). This
is consistent with our previous observation that 2i cultures
contain totipotent cells (Morgani et al., 2013). In addition,
2i-cultured ESCs showed a correlation with E3.5 early Epi
(Figure 2G and Table 3, z = 7.4), whichmay reflect a second
population of Epi-like Nanog-positive, Hhex-negative cells.
As KOSR-cultured ESCs express endoderm markers, it is
not surprising that gene expression in these conditions
correlates with all stages of PrE development (Figure 2G
and Table 3, E3.5 PrE z = 7.5, E4.5 PrE z = 9.4). Conversely,Stem Cell Reports j Vol. 7 j 177–191 j August 9, 2016 181
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gene expression in serum-cultured ESCs is correlated with
later E4.5 embryos (Figure 2G and Table 3, E4.5 Epi z =
4.5, E4.5 PrE z = 3.3) when Epi and PrE are fully specified
and functionally restricted (Grabarek et al., 2012). As
ESCs cultured in serum undergo a degree of spontaneous
differentiation into cell types reminiscent of the later
embryo, these differentiated cells could also contribute to
the increased correlation of the serum transcriptome to
later developmental stages. This spontaneous differentia-
tion is inhibited by culture in either 2i or KOSR.
2i- and KOSR-Cultured ESCs Can Contribute to 2C
Embryos
As gene-expression profiles of 2i and KOSR-cultured ESCs
correlated with the early blastocyst (Figure 2G), in addition
to containing subpopulations that coexpressed embryonic
and extraembryonic determinants (Figure 2E) (Morgani
et al., 2013), reminiscent of early developmental stages,
we asked whether they showed a correlation to even earlier
stages of development. We compared our microarray data
with RNA-sequencing data on oocytes and 2C embryos
(Macfarlan et al., 2012) (ExAtlas, FDR %0.05, fold
change R2). Gene expression of ESCs cultured in 2i and
KOSR was correlated with data from 2C embryos, but not
oocytes (Figure 3A, z values of 5.1 and 2.4, respectively).
However, these correlations were not as strong as those to
later stages of development (Figure 2G). Conversely,
serum-cultured ESCs showed a correlation with oocytes
(z = 5.6) but not 2C embryos (z = 5.6) (Figure 3A). This
may be a result of the correlation in gene expression be-
tween the late blastocyst and oocytes that we found
when re-analyzing published datasets (Figure S3A). To
further assess the significance of a potential 2C-like popula-
tion, we asked whether culture in different conditions
could induce the expression of a reporter for the 2C-specific
marker (Falco et al., 2007; Hirata et al., 2012), Zscan4. AnFigure 2. KOSR, Serum, and 2i Support Unique Transcriptional St
(A and B) Microarrays were carried out on 129/Ola ESCs cultured in se
independent ESC lines were analyzed per condition. (A) Pairwise com
between serum-cultured and 2i- or KOSR-cultured ESCs to reveal n
represent significantly upregulated genes, green dots represent signifi
not significantly changing in expression. (B) Expression changes i
expression in standard serum cultures.
(C) Venn diagrams illustrating the overlap between genes up- and dow
(identified in A).
(D and E) Flow cytometry profiles and corresponding mean fluorescenc
serum, 2i, and KOSR. n = 3 independent experiments. Error bars indic
Student’s unpaired t test.
(F) Confocal optical section of ESCs cultured in serum, 2i, and KOSR im
coexpressing ESCs. The same observation was made in two independe
(G) Graph showing the correlation of serum-, 2i-, and KOSR-cultured
(Ohnishi et al., 2014).
See also Figure S2.induction of Zscan4-Emerald was observed in both 2i and
KOSR (Figures 3B and S3B).
Based on the capacity of 2i- and KOSR-cultured ESCs to
stimulate extraembryonic and 2C gene expression, we
asked whether they were capable of contributing to the
earliest stages of embryonic development. We injected
single 2i-cultured ESCs labeled with H2B-Tomato into 2C
embryos (Figure 3C). In the majority of cases (n = 8/9),
100% of NANOG+ Epi cells were generated from the single
injected ESC (Figures 3D, S3C, and S3D).We also observed a
contribution of ESC progeny to the extraembryonic
trophoblast (Figure S3C). While 2i-cultured ESCs intro-
duced at the 2C stage divided and populated the ICM,
the majority of serum-cultured cells were excluded during
pre-implantation development (Figures S3E and S3F).
Despite the high levels of chimerism observed in single-
cell injections as late as mid-gestation (Figure S3D) (Mor-
gani et al., 2013), no live-born chimeras were obtained
from 129/Ola lines injected as single cells. In contrast,
full-term ESC-derived mice were obtained from the injec-
tion of single F1 129S2;C57BL/6N hybrid 2i- or KOSR-
cultured ESCs, but not from those cultured in serum (Fig-
ures 3G–3I and Table 1). As with morula injections, these
mice showed a high, virtually homogeneous contribution
to ectoderm, judged by coat color and internal organs (Fig-
ures S3G and S3I). All tested ESC-derived mice contributed
to the germline (n = 5/5, Table 2). Similar to the single-cell
morula injections (Figures 1G and 1I), transfer of serum-
derived ESCs to 2i culture endowed these cell lines with
the capacity to contribute to 2C embryos (Figures 3F and
3G; Table 1). In addition, when 2i-derived ESCs were
switched to serum-containing medium, either directly or
by gradual adaptation, these cells lost this capacity
(Figure 3F).
We then asked whether the inability of serum-cultured
ESCs to contribute to 2C embryos was due to theirates
rum, 2i, and KOSR conditions. At least three biological replicates of
parisons (FDR <0.05, R2-fold expression levels) were performed
on-redundant, significant changes in gene expression. Red dots
cantly downregulated genes, and gray dots represent genes that are
n lineage markers in 2i- and KOSR-cultured ESCs relative to the
nregulated in 2i and KOSR compared with standard serum cultures
e values for PECAM-1+ HV (D) or Nanog-GFP TNGB (E) ESCs cultured in
ate SD of the mean. **p% 0.01, ***p% 0.001, ****p% 0.0001,
munostained for GATA6, OCT4, SOX2, and NANOG. Asterisks indicate
nt cell lines.
ESCs with published microarray data of different embryonic stages
Stem Cell Reports j Vol. 7 j 177–191 j August 9, 2016 183
Table 3. Lists of Genes Correlated between 2i- and KOSR-Cultured ESCs and Different Stages of Embryonic Development, Related
to Figure 2
Symbols EPFP Gene Title RefSeq
E3.25 versus 2i (z Value, 3.508; Correlation, 0.1001)
Bhmt2 0.0237 betaine-homocysteine methyltransferase 2 NM_022884
Spic 0.0283 Spi-C transcription factor (Spi-1/PU.1 related) NM_011461
Jakmip1 0.1569 janus kinase and microtubule interacting protein 1 NM_178394
Ly6a 0.2471 lymphocyte antigen 6 complex, locus A NM_010738
Gsc 0.2702 goosecoid homeobox NM_010351
Rab38 0.2745 RAB38, member of RAS oncogene family NM_028238
Khdc1a 0.2745 KH domain-containing 1A NM_183322
Fxyd4 0.2859 FXYD domain-containing ion transport regulator 4 NM_033648
Bdh1 0.319 3-hydroxybutyrate dehydrogenase, type 1 NM_175177
Bcl2l14 0.3263 BCL2-like 14 (apoptosis facilitator) NM_025778
Cdkn1a 0.4118 cyclin-dependent kinase inhibitor 1A (P21) NM_007669
Gss 0.4612 glutathione synthetase NM_008180
Pdp2 0.4887 pyruvate dehydrogenase phosphatase catalytic subunit 2 NM_001024606
E3.25 versus KOSR (z Value, 3.59; Correlation, 0.1024)
Pdgfra 0.1396 platelet-derived growth factor receptor, a polypeptide NM_011058
Cphx1 0.3658 cytoplasmic polyadenylated homeobox 1 NM_175342
Gata6 0.3658 GATA binding protein 6 NM_010258
Pnliprp2 0.3658 pancreatic lipase-related protein 2 NM_011128
E3.5 Epi versus 2i (z Value, 7.351; Correlation, 0.2063)
Spic 0.0087 Spi-C transcription factor (Spi-1/PU.1 related) NM_011461
Gsc 0.1293 goosecoid homeobox NM_010351
Aspa 0.1293 aspartoacylase NM_023113
Gsta2 0.1293 glutathione S-transferase, a 2 (Yc2) NM_008182
Mal 0.3835 myelin and lymphocyte protein, T cell differentiation protein NM_010762
Khdc1a 0.4185 KH domain-containing 1A NM_183322
E3.5 PrE versus KOSR (z Value, 7.538; Correlation, 0.2113)
Pdgfra 0.1232 platelet-derived growth factor receptor, a polypeptide NM_011058
Cubn 0.1416 cubilin (intrinsic factor-cobalamin receptor) NM_001081084
Tcf23 0.1416 transcription factor 23 NM_053085
Gata4 0.236 GATA binding protein 4 NM_008092
Cpn1 0.236 carboxypeptidase N, polypeptide 1 NM_030703
Gata6 0.2364 GATA binding protein 6 NM_010258
Gdpd5 0.2364 glycerophosphodiester phosphodiesterase domain-containing 5 NM_201352
(Continued on next page)
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Table 3. Continued
Symbols EPFP Gene Title RefSeq
Srgn 0.2364 serglycin NM_011157
Meis1 0.2364 Meis homeobox 1 NM_010789
Sox17 0.2364 SRY (sex determining region Y)-box 17 NM_011441
Pth1r 0.2389 parathyroid hormone 1 receptor NM_011199
Bmp6 0.247 bone morphogenetic protein 6 NM_007556
Aqp8 0.26 aquaporin 8 NM_007474
E4.5 PrE versus KOSR (z Value, 9.405; Correlation, 0.2604)
Cubn 0.0421 cubilin (intrinsic factor-cobalamin receptor) NM_001081084
Sox7 0.3368 SRY (sex determining region Y)-box 7 NM_011446
Srgn 0.3378 serglycin NM_011157
Nostrin 0.3378 nitric oxide synthase trafficker NM_181547
Pdgfra 0.3378 platelet-derived growth factor receptor, a polypeptide NM_011058
Sox17 0.3439 SRY (sex determining region Y)-box 17 NM_011441
Gata4 0.3536 GATA binding protein 4 NM_008092
Pth1r 0.3953 parathyroid hormone 1 receptor NM_011199
Ctsh 0.4678 cathepsin H NM_007801
Pearson correlation of our microarray data of ESCs cultured in serum, 2i, and KOSR and microarrays on different stages of embryonic development (Ohnishi
et al., 2014) was determined using ExAtlas online tool for gene expression meta-analysis. The list of correlated genes (FDR %0.1, fold change R1.5),
z value, and correlation value is shown. EPFP, expected proportion of false positives.previously observed reduced clonogenicity (Figure 1G).We
injected five ESCs into 2C embryos but no full-term
chimeras were obtained (Figure 3H and Table 1). When
these serum-derived ESCs were switched to 2i culture, the
injection of multiple ESCs into 2C embryos resulted in
six out of seven 100% ESC-derived mice (Figure 3H and
Table 1). This suggests that, as well as exhibiting a lower
level of clonogenicity in morula injection, serum-cultured
ESCs cannot contribute to early 2C embryos, even when
injected as multiple cells.
We recently showed that a totipotent fraction of
2i-cultured cells is characterized by the expression of an
HVtransgene and the coexpressionof embryonic andextra-
embryonic determinants within individual cells (Morgani
et al., 2013). These cells also demonstrated an enhanced
capacity to differentiate toward the extraembryonic line-
ages. As KOSR-cultured ESCs coexpressed embryonic and
extraembryonicmarkers and demonstrated a similar clonal
capacity to contribute to early pre-implantation develop-
ment,we askedwhetherKOSR-cultured cells could generate
extraembryonic cell types, both trophoblast and extraem-
bryonic endoderm (XEN). We have previously shown that
2i-cultured ESCs generate CDX2+ trophoblast-like cells
whencultured in trophoblast stemcell (TSC)medium(Mor-gani et al., 2013). ESCs cultured in either serumor KOSR did
not have this capacity (Figure S3K). Serum-cultured ESCs
died after two passages while KOSR-cultured cells survived
but did not express CDX2.However, when ESCswere trans-
ferred to XEN cell media, in the absence of lineage-promot-
ing cytokines, both KOSR and 2i-cultured ESCs displayed a
XEN-like morphology, downregulated the pluripotency
marker NANOG, and expressed the endoderm marker
GATA6 (Figures 3I and 3J). While the majority of serum-
culturedESCsdownregulatedNANOG, theydidnot express
GATA6. Preliminary data from injections of KOSR-cultured
ESCs into morulae suggests that these cells may also to
contribute to both embryonic and extraembryonic lineages
in vivo (Figure S3J). Taken together, these data indicate that
ESCs cultured in 2i or KOSR have the capacity to generate
extraembryonic lineages and this correlates with their
gene-expression profiles, in addition to their capacity to
colonize 2C embryos.DISCUSSION
In this paper we have shown that the culture conditions in
which ESCs are grown can be used to re-program theirStem Cell Reports j Vol. 7 j 177–191 j August 9, 2016 185
Figure 3. 2i and KOSR ESCs Can Form 100% ESC-Derived Mice When Injected into 2C Embryos
ESCs were derived (D) in and cultured (C) under various conditions; D and C in serum, D in serum and C in 2i, D and C in 2i, D in 2i and C in
serum, and D and C in KOSR. Single ESCs from each of these conditions were injected into 2C embryos.
(A) Graph showing the correlation of serum-, 2i-, and KOSR-cultured ESCs with published microarray data of oocytes and 2C embryos
(Macfarlan et al., 2012).
(B) Flow cytometry profiles for Zscan4-Emerald ESCs, immunostained for the marker of undifferentiated ESCs PECAM-1, cultured in serum,
2i, and KOSR.
(C) Representative 2C embryos immediately after injection with a single ESC expressing a constitutive H2B-Tomato marker.
(D) Confocal optical sections of an immunostained late blastocyst resulting from the injection of a single 2i-cultured ESC, expressing a
constitutive H2B-Tomato marker, into a 2C embryo.
(E) Representative images of litters containing 100% ESC-derived agouti mice generated from the injection of a single 2i- or KOSR-cultured
cell into a 2C embryo, along wild-type C57BL/6 littermates. Asterisks indicate mice with ESC contribution.
(F and G) Single ESCs were injected into 2C embryos and their contribution to full-term chimeras assessed according to coat color. (F) Graph
showing the percentage of chimeras born out of the total number of pups and quantification of coat color chimerism. n Values are provided
(legend continued on next page)
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potency irrespective of the protocol by which they were
derived. Single ESCs cultured in 2i and KOSR culture condi-
tions demonstrated the capacity to contribute effectively to
embryonic development from both the morula and 2C
stage. Moreover, this enhanced capacity to contribute to
embryonic development correlated with the expression
of extraembryonic-associated RNAs and 2C determinants.
Thus, while pluripotency factors were expressed in all three
culture conditions, ESCs showed distinct gene-expression
profiles, and these profiles appear to be correlated with
cell behavior in vivo.
Canonical ESC derivation protocols yield variable effi-
ciencies depending on the genetic background of the
mice used (Auerbach et al., 2000; Brook and Gardner,
1997). Using improved ESC derivation protocols, it is
now possible to generate ESCs from a variety of back-
grounds (Nichols et al., 2009a; Nichols and Ying, 2006;
Yang et al., 2009; Ying et al., 2008). Although we analyzed
inbred (129) and outbred (F1) genetic backgrounds in this
study, to compare different derivation approaches we
started with embryos of an F1 genetic background known
to generate high-quality ESC lines based on hybrid vigor
(Eggan et al., 2001; Rideout et al., 2000). The ability of
single ESCs to contribute to 2C or morula stages was
independent of background, but the capacity to generate
live-born entirely ESC-derived mice appeared to be linked
to an F1 genetic background. However, as the 129 ESCs
used in this study have been in culture for longer periods,
cultural adaptation may contribute to this reduced effi-
ciency. Nevertheless, previous data show that F1 hybrid
ESC lines produce viable offspringwith increased efficiency
and suggest that genetic heterozygosity is a requirement to
support post-natal development of entirely ESC-derived
mice (Eggan et al., 2001; Kirchain et al., 2008).
Previous studies suggest that approximately one out of
ten serum-cultured ESCs contribute to embryonic develop-
ment (Wang and Jaenisch, 2004). If 2i and KOSR cultures
generated more single-cell chimeras by increasing the pro-
portion of functionally potent ESCs, we would also expect
to observe some chimeras from serum-cultured ESCs
(n = 87 injected embryos). As a result, it is not merely
that serum-cultured ESCs contain fewer ‘‘pluripotent’’ cells,above bars and refer to the number of independent ESC clones that w
sentative images of full-term mice generated from the injection of sin
panel), into 2C embryos. Asterisks indicate mice with ESC contributio
(H) Graph showing the percentage of chimeras born out of the total n
are provided above bars and refer to the number of independent ESC
(I) ESCs were pre-cultured in serum, 2i, or KOSR for three passages an
representative colonies.
(J) Quantification of the average proportion of colonies under each co
with >20 GATA6+ cells and those with <20 GATA6+ cells. Error bars in
See also Figure S3.but that their clonogenic capacity to self-renew is limited.
The increased functional potential of individual 2i-
cultured (Morgani et al., 2013) and KOSR-cultured ESCs
to generate embryonic and extraembryonic lineages could
be a feature of their increased clonogenicity. It has previ-
ously been shown that ESCs cultured in the presence of
the 2i inhibitors as well as an FGF receptor inhibitor (3i)
exhibit increased clonogenicity compared with serum-
cultured cells in vitro (Ying et al., 2008), and single 2i-
cultured cells show an increased capacity to generate
multiple cell types in differentiation assays (Morgani
et al., 2013). If 2i- and KOSR-cultured ESCs undergo
increased numbers of self-renewing cell divisions, even in
the presence of signals that promote lineage restriction,
they may generate a critical mass to effectively contribute
to both Epi and extraembryonic lineages. In support of
this hypothesis, ESC clones exhibiting a greater rate of pro-
liferation generate a higher number of chimeras than those
with slower proliferation rates (Wang and Jaenisch, 2004).
Although individual clonogenic ESCs can appear toti-
potent, the fraction of these cells in different culture
conditions may vary, and this could explain why aggregate
gene-expression data indicate that 2i cells represent
distinct developmental stages (Boroviak et al., 2014). Here
we find two clear signatures in the 2i dataset, early pre-im-
plantation development and Epi, perhaps representing this
heterogeneity.
We also observed that ESC culture in KOSR enhances
their functional potency. At a transcriptional and func-
tional level, these cells are biased toward endoderm. This
is distinct from cells cultured in 2i that can differentiate
into both trophoblast and extraembryonic endoderm
in vitro and in vivo (Morgani et al., 2013). However, ESCs
grown and derived in either condition exhibit enhanced
potency on a single-cell level. Thus ESC culture conditions
may enhance potency by promoting competence for extra-
embryonic lineages. Moreover, a number of recent reports
on ESC totipotency use KOSR in their culture medium
(Abad et al., 2013; Macfarlan et al., 2012). As a result, it
is intriguing to speculate that this media condition can
enhance the reprogramming of normal ESCs to a totipo-
tent, clonogenic state.ere tested for each condition. Error bars indicate SEM. (G) Repre-
gle-cell ESCs, D and C in serum (upper panel), or D and C in 2i (lower
n.
umber of pups and quantification of coat color chimerism. n Values
clones tested for each condition.
d then switched to XEN cell medium for two passages. Images show
ndition expressing GATA6. A distinction was made between colonies
dicate SD of the mean of five randomly selected fields of view.
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EXPERIMENTAL PROCEDURES
Mouse Line Maintenance
Mouse lines were maintained under 12/12-hr light/dark cycles in
the designated facilities at the University of Copenhagen. Mice
were checked for copulation plugs each morning and embryos
were considered embryonic day 0.5 (E0.5) on the day of plug detec-
tion. All animal work was carried in accordance with European
legislation. All work was authorized by and carried out under Proj-
ect License 2012-15-2934-00743 issued by the Danish Regulatory
Authority.
ESC Line Derivation
ESCs derived in this study were F1 hybrid 129S2;C57BL/6N, and
129S6;C57BL/6N lines. Embryos were obtained from mice sup-
plied by commercial vendors with their corresponding certificates
(129S6, Taconic; 129S2, Charles River; C57BL/6, Harlan). Females
were superovulated at 4 (C57BL/6) or 7 (129) weeks old and
mated with fertile males (8–24 weeks old). For derivation in 2i,
E2.5 embryos were flushed from oviducts in M2 medium and
cultured in KSOM (Millipore) for approximately 8 hr until the
evening where they were transferred to KSOM + 2i (1 mM
PD0325901, Stemgent; 3 mM CHIR99021, Biovision). Embryos
were cultured overnight until E3.5 blastocysts, then transferred
to individual wells of gelatinized 96-well plates containing
2i/LIF ESC culture medium (2i inhibitors in N2B27 medium).
Embryos were cultured for 5–8 days at 37C, 5% CO2, and 90%
humidity, until a cluster of cells generated from the ICM
emerged. ICM outgrowths were picked and dissociated into
smaller clusters in Accutase (Sigma) for 3–5 min at 37C before
being plated into fresh medium for expansion. The same protocol
was used to derive ESCs in serum and KOSR conditions but with
pre-culture of embryos in KSOM alone and then transfer to 96-
well plates containing either serum/LIF or KOSR/LIF. Derivation
of ESC lines in serum/LIF and KOSR/LIF was only possible on
mouse embryonic fibroblasts (MEFs), although in 2i/LIF condi-
tions ESCs could be derived on gelatin.
ESC Culture
ESC lines were maintained in serum/LIF (Canham et al., 2010), 2i/
LIF (Ying et al., 2008) as previously described or KOSR/LIFmedium
(80% Knockout DMEM [Gibco], 20% Knockout Serum Replace-
ment [Gibco], non-essential amino acids [Gibco], glutamine and
sodium pyruvate [Gibco], 0.1 mM b-mercaptoethanol [Sigma]).
H2B-Tomato ESCs were generated using E14 ESCs from the 129/
Ola background (Morgani et al., 2013). Newly derived ESC lines
described are F1 hybrid 129S6;C57BL/6N lines. F1 hybrid lines
are named as follows. 2i-derived lines: TCF2.2, TCF2.5, TCF2.6;
serum-derived lines: TCF3.4, TCF3.5; KOSR-derived lines:
TCF5.30, TCF5.45. ESC lines were switched from their original
derivation medium to alternative medium conditions. In the
case of serum-cultured cells, ESCs were maintained in the serum
for a minimum of 12 passages before being switched to 2i for three
passages prior to injection. F1 ESC lines were also electroporated
with a constitutive pCAG Kozak-Venus marker (a kind gift from
Dr. Heiko Lickert). Zscan4-Emerald ESCs were obtained from the
Ko laboratory (Zalzman et al., 2010).188 Stem Cell Reports j Vol. 7 j 177–191 j August 9, 2016XEN and TSC Differentiation Assays
For XEN cell differentiation, ESCs were cultured for three passages
in serum, 2i, or KOSR and transferred to XEN cell medium (RPMI
[Sigma], 15% fetal bovine serum, glutamine and sodium pyruvate,
0.1 mM b-mercaptoethanol) for two passages (6 days total). Cells
were immunostained for GATA6 andNANOG and the average pro-
portion of GATA6+ colonies was quantified using five random
fields of view per condition. As there was variation in the number
of GATA6+ cells/colony, we distinguished between colonies with
<20 GATA6+ cells or >20 GATA6+ cells. Overall colony size did
not significantly differ. For TSC differentiation, ESCs were cultured
for three passages in serum, 2i, or KOSR, then transferred to TSC
medium for three passages (total 6 days) (Tanaka et al., 1998).
Resultant cultures were stained for CDX2.
Alkaline Phosphatase Staining
ESCs were plated at clonal density and cultured for 9–10 days.
Alkaline phosphatase staining was carried out as per manufac-
turer’s instructions. Colonies were imaged using a Nikon AZ-100
microscope.
Chimera Generation and Embryo Culture
Embryoswere obtained as for ESC derivation. Single ormultiple (5)
ESCs were injected into 2C or 8-cell embryos. Inbred cell lines were
sorted by flow cytometry prior to injection (Figure S3F) as previ-
ously described (Morgani et al., 2013). For 2C embryo injection,
E1.5 wild-type C57BL/6N embryos were flushed from oviducts.
Embryos were de-compacted in PB1 medium without calcium
and magnesium for 20 min at room temperature and a single cell
introduced bymicroinjection. The same process was used for injec-
tion of E2.5 morula. Resultant embryos were cultured ex vivo in
KSOMmicrodrops covered with mineral oil (Sigma) or transferred
to pseudopregnant CD1 females (8–13 weeks old) and allowed to
develop to term.
Microarray Analysis
Unsorted ESCs were maintained in serum/LIF, 2i/LIF, or KOSR/LIF.
Samples were collected from three independent ESC clones from
the 129/Ola background: E14, HVJu5.1, and HVJu9.3 (Morgani
et al., 2013). For 2i/LIF, five samples were collected with two sam-
ples each for HVJu5.1 and HVJu9.3 cell lines; for serum/LIF and
KOSR/LIF conditions, one sample was collected for each cell line.
Each condition is represented at least as biological triplicates.
RNA isolation was performed using Qiagen RNeasy kits according
to the manufacturer’s instructions. RNA pellets were re-suspended
in Nuclease Free Water (Ambion) and RNA concentration was
measured using the Nanodrop system. 260/280 values for all
samples were in the range of 1.8–2.0. RNA quality was additionally
assessed using the Agilent 2100 BioAnalyzer with all samples
having a RIN of R9.7. Transcriptome analysis was carried out
in-house with one-color 8 3 60K Mouse Gene Expression
Microarrays (Agilent Technologies, G4852A) as per manufacturer’s
instructions. In brief, 150 ng of total RNA was labeled using the
Low Input Quick Amp Labeling Kit (Agilent Technologies, 5190-
2305). Labeled samples were hybridized overnight, then washed
and scanned using the high-sensitivity protocol (AgilentG3_
HiSen_GX_1color) on a SureScan microarray scanner (Agilent
Technologies). Probe intensities were obtained by taking the
gProcessedSignal from the output of Agilent feature extraction
software using default settings. Probe intensities were analyzed
using the NIA Array Analysis tool (http://lgsun.grc.nia.nih.
gov/ANOVA/).
Analysis of microarray data was carried out using ExAtlas online
tool for meta-analysis of gene-expression data developed by the
NIA (http://lgsun.grc.nia.nih.gov/exatlas/) (Sharov et al., 2015).
Pearson correlation between datasets was measured using the
following parameters: false discovery rate (FDR) %0.05, fold
changeR2, angle 0.8, expected proportion of false positives (EPFP)
0.5. To obtain correlating gene lists (Table S10), the following
parameters were used: FDR 0.1, fold changeR1.5, angle 0.8, EPFP
0.5. Gene ontology analysis was performed using the Gene
Ontology Consortium online tool (http://geneontology.org).
Immunostaining of ESCs
ESCs were plated in ibiTreat 15 m-Slide 8-well dishes (Ibidi). ESCs
were immunostained as described by Canham et al. (2010). Pri-
mary antibodies were used at the following concentrations:
Gata6 (R&D, AF1700 [Morgani et al., 2013]) 1:100, Gata6 D61 3
104 XP (Cell Signaling, 5851 [Lim et al., 2014]) 1:200, Oct4 (C-10
Santa Cruz Biotechnology, sc5279 [Hall et al., 2009]) 1:100, Sox2
(Santa Cruz, sc17320 [Huang et al., 2012]) 1:100, Nanog
(eBioscience, 14-5761 [Morgani et al., 2013]) 1:200, Cdx2
(MU392A, Biogenex [Nichols et al., 2009b]) 1:200. Alexa Fluor sec-
ondary antibodies (Invitrogen) were diluted 1:500. When immu-
nostaining for HV, a conjugated anti-GFP-Alexa 488 antibody
(1:200, Molecular Probes, A21311 [Morgani et al., 2013]) was
added at the same time as the secondary antibodies. Cells were
imaged on a Leica TCS SP8.
Immunostaining of Embryos
Immunostaining of embryos was carried out as described by Nich-
ols et al. (2009b). The primary antibodies were used at the
following dilutions: Nanog (eBioscience, 14-5761 [Le Bin et al.,
2014]) 1:200, Cdx2 (Biogenex, MU392A-UC [Nichols et al.,
2009b]) 1:200. Alexa Fluor secondary antibodies were used at
1:500. Embryos were imaged in an Attofluor chamber (Life Tech-
nologies) on a 25-mm glass coverslip using a Leica TCS SP8
confocal.
Organ Disaggregation and Flow Cytometry
Internal organs were dissected in PB1 medium and imaged using a
Nikon AZ100. A section of organ was manually disaggregated with
scissors in PBS. Dissociated tissuewas disaggregated in trypsinwith
20 mL/mLDNase (Qiagen) while shaking at 37C for 15min. Disag-
gregated Kozak-Venus chimeric organs were re-suspended in PBS
with 100 ng/mL DAPI and analyzed. The disaggregated spleen of
chimeric mice generated from unlabeled 129 ESCs was re-sus-
pended in PBS containing 1:50 anti-CD229.1-APC 30C7 conju-
gated antibody (560188, BD Pharmingen [Tawara et al., 2012]).
Cells were incubated on ice for 15 min, then washed three times
with PBS before being re-suspended in PBS with 100 ng/mL
DAPI. Data were collected using a BD LSR Fortessa. Flow cytometry
analysis was carried out using FlowJo software (Tree Star) first by
gating on forward and side scatter to identify a cell populationand eliminate debris, then to gate DAPI-negative, viable cells
before assessing the level of Venus or APC. PDGFRa flow cytometry
was carried out as described by Rugg-Gunn et al. (2012).
Antibody Staining and Flow Cytometry of ESCs
ESCs were collected by trypsinization, and antibody staining for
PECAM-1 (BD Pharmingen, 551262 [Morgani et al., 2013]) was car-
ried out as described by Canham et al. (2010). Data were collected
using a BD LSR Fortessa. Flow cytometry analysis was carried out
using FlowJo software (Tree Star) first by gating on forward and
side scatter to identify a cell population and eliminate debris,
then to gate DAPI-negative, viable cells and PECAM-1-APC-posi-
tive cells, before assessing the level of Venus or GFP. For Zscan4-
Emerald analysis, gating was based on E14 wild-type ESCs.
qRT-PCR
Three independent ESC lines (E14, HVJu5.1, and HVJu9.3) were
cultured in serum/LIF, 2i/LIF, or KOSR/LIF for three passages.
RNA was isolated from cells (RNeasy, Qiagen). cDNA was synthe-
sized from 1 mg of RNA using Superscript III according to the man-
ufacturer’s guidelines (Invitrogen). qRT-PCR was carried out on a
Lightcycler480 (Roche) using UPL technology (Roche) utilizing
primer sequences specified in Supplemental Experimental Proce-
dures. Primers were used at a concentration of 1 mM. The geometric
mean of the housekeeping genesTbp,Gapdh, and Pgk1was used for
normalization of Ct values detected for each sample.
Statistical Analysis
Statistical analysis was performed using the QuickCalc GraphPad
(http://www.graphpad.com/quickcalcs/index.cfm). For non-para-
metric data, two-tailed chi-square tests were performed. For para-
metric data comparing two samples, an unpaired Student’s t test
was used. A p value is shown when the difference between
compared groups is significant. The statistical significance of the
overlap of gene lists was assessed using http://nemates.org/MA/
progs/overlap_stats.cgi, using a genome size of 25,000. The repre-
sentation factor is the number of overlapping genes divided by
the expected number of overlapping genes drawn from two
random, independent groups. A representation factor >1 indicates
a greater overlap than expected by chance.
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